Clinical trial updates in cancer care include a remote study in small cell lung cancer and new findings in ovarian, solid ...

In the Chinese mainland, toripalimab was the first domestic anti-PD-1 monoclonal antibody approved for marketing (approved in China as TUOYI®). Currently, there are twelve approved indications for ...

The anti-CALB2 antibody gives labs a reliable way to find caltrentinin with clarity and control. From brain mapping to tumor screening, the anti-CALB2 antibody helps researchers focus on things that ...